AgomAb Therapeutics CEO reports Form 4P purchase
Form 4P filed by AgomAb Therapeutics NV shows CEO Tim Jasper P Knotnerus purchased 11,000 shares at $8.58 for $94,380.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.